Determinants of Continuous Glucose Monitoring Accuracy in Critically Ill Patients Requiring Mechanical Ventilation and Vasopressor Support
Ola Friman, Samuel Wiqvist, Marcus Lind, Pia Zetterqvist, Olav Rooijackers, Anders Oldner, Johan MårtenssonBackground:
Continuous glucose monitoring (CGM) accuracy in critically ill patients may be influenced by altered physiology and concurrent therapies. We assessed independent associations between sensor wear time, arterial blood glucose (ABG), noradrenaline-equivalent (NE) dose, erythrocyte volume fraction, pH, lactate, body-mass index and dialysis to CGM performance (Dexcom G6 ® ) in this setting.
Methods:
Secondary analysis of a prospective observational study including 40 critically ill adults receiving intravenous insulin, mechanical ventilation and vasopressor therapy. Paired ABG and CGM values (
Results:
Median (IQR) ARD was 10.8% (5.2–18.8) (mean ARD 12.7 [95% CI 10.7–15.3] %); 64.5% and 56.0% of readings met ISO and CLSI criteria, respectively. Sensor wear time (
Conclusions:
In critically ill patients receiving mechanical ventilation and vasopressor therapy, CGM accuracy improves substantially with increasing sensor wear time and is independently associated with arterial pH. Early postinsertion sensor instability and acid–base disturbances appear to be important determinants of CGM performance in critical illness.